CLOV vs LYRA
Clover Health Investments Corp (CLOV) versus Lyra Therapeutics Inc (LYRA) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported LYRA revenue for 2024-12-31 was $1.5M. Net income was -$93.4M. Revenue was down 1.5% from 2023-12-31 to 2024-12-31. LYRA currently screens at market cap $14.4M.
CLOV currently screens at market cap $1.55B. LYRA currently screens at market cap $14.4M.
Not investment advice. Open the CLOV and LYRA stock pages for the full models.
Not investment advice.